On September 20, 2016, the Senate HELP committee held a hearing on precision medicine and regulation. Topics included FDA regulation of LDTs.
For an unofficial transcript in the cloud, click HERE.
Testimony was provided by David Klimstra, Dept. Pathology, Memorial Sloan Kettering; Brad Spring, BD Life Sciences; Jeff Allan, Friends of Cancer Research; and Karen Kaul, Pathology, University of Chicago.
See files and video online here
Coverage at Genomeweb, here